Mallinckrodt plc announced that Gary Phillips has been appointed to serve as Senior Vice President and President of the company's Autoimmune and Rare Disease business, which includes the commercial organization supporting H.P. Acthar(R) Gel. Additionally, Ray Furey, formerly Senior Vice President and Chief Compliance Officer at Questcor Pharmaceuticals, has been appointed as Senior Vice President and the Chief Compliance Officer at Mallinckrodt. The appointments are effective immediately.

In his new role, Dr. Phillips will assume responsibility for the Acthar franchise and all of its sales, support and service activities. Both executives will report directly to Mark Trudeau, Chief Executive Officer of Mallinckrodt.